Please login to the form below

MDR

This page shows the latest MDR news and features for those working in and with pharma, biotech and healthcare.

Merck preps regulatory filings for much-needed antibiotic combo

An independent UK review estimated that by 2050 MDR infections could claim 10 million lives a year and result in a cumulative loss from global output of $100trn. ... rates of multidrug resistant (MDR) strains, the need for new treatment options is

Latest news

Pharma must do more on antibiotic resistance, Davos meeting hears

In particular, more needs to be done to bring forward new drugs for multidrug resistant (MDR) pathogens or ‘superbugs’ - there are currently 28 novel drugs for high-priority pathogens in phase
Pfizer launches antibiotic resistance surveillance website

Meanwhile, Pfizer’s new antibiotic for multidrug resistant (MDR) infections, Zavicefta, was launched in its first European markets earlier this year after the pharma firm paid its developer AstraZeneca $1.58bn
Pfizer launches new antibiotic Zavicefta in UK and Germany

MDR infections are an increasing global threat," said Matteo Bassetti, chief of the infectious diseases Clinic at University of Udine in Italy. ... The availability of Zavicefta is a major step forward for physicians faced with the challenge of treating
AZ slims down again with sale of antibiotics to Pfizer

ATM-AVI is in trials for life-threatening Gram-negative bacterial infections caused by multi-drug resistant (MDR) strains, while CXL has activity against MDR Gram-positive and Gram-negative pathogens.
AZ gets EU green light for new antibiotic Zavicefta

EMA approves combination drug for treatment of multidrug resistant infections. AstraZeneca's new antibiotic for multidrug resistant (MDR) infections - Zavicefta - has been approved for marketing in the EU. ... In 2014 Professor Sally Davies, the UK Chief

More from news
Approximately 4 fully matching, plus 26 partially matching documents found.

Latest Intelligence

Medical device regulation - a risk-based approach to compliance

Simply put, complying with MDR is another stressor for medtechs at an already challenging time, potentially affecting both top- and bottom-line growth. ... It's difficult to estimate just how great the costs associated with MDR implementation will

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Account Director or Senior Account Director: Salary TBC

Account Manager– Medical Communications: (Negotiable - depending on experience)

Consultant: competitive salary

Senior Medical Writer, MedComms Agency: Salary TBC

Director of Scientific Services, Medical Communications, Six fig...: Six figure salary

Principal Medical Writer: £48 - 58, 000 according to skills and experience benefits

Vice President: Competitive Salary Offered

Subscribe to our email news alerts

PMHub

Add my company

Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Happy Chinese New Year 2020 - The Year of The Rat: A fond farewell to The Year of the Pig...
White Paper for download - Explaining the price of your product: In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team: Enhanced expertise to deliver impactful internal training programmes for healthcare clients...